0,949  0,001  NOS2 expression inhibitor
0,942  0,004  Antidiabetic
0,942  0,004  Cyclophilin D inhibitor
0,939  0,002  Antimutagenic
0,939  0,003  Mutagenic
0,904  0,003  Hypoglycemic
0,894  0,002  UGT1A9 substrate
0,895  0,004  Antioxidant
0,879  0,003  Genotoxic
0,879  0,004  Cytostatic
0,873  0,003  AR expression inhibitor
0,870  0,004  Radioprotector
0,868  0,003  Cardioprotectant
0,864  0,003  Vasodilator, coronary
0,859  0,005  Caspase 9 stimulant
0,851  0,003  Monophenol monooxygenase inhibitor
0,852  0,004  Chemopreventive
0,825  0,011  Transcription factor NF kappa B inhibitor
0,815  0,003  UGT1A1 substrate
0,820  0,014  Apoptosis agonist
0,805  0,004  Free radical scavenger
0,802  0,005  Chemoprotective
0,788  0,002  Melanin inhibitor
0,790  0,019  Alpha-glucosidase inhibitor
0,756  0,022  Antiinflammatory
0,743  0,009  Carcinogenic
0,717  0,003  Amylase inhibitor
0,714  0,005  Antipyretic
0,709  0,005  Hepatic disorders treatment
0,706  0,005  Antidiabetic (type 2)
0,704  0,003  NOS3 expression enhancer
0,705  0,013  Antileukemic
0,693  0,004  Apoptosis antagonist
0,694  0,007  Proliferative diseases treatment
0,687  0,003  Xanthine oxidase inhibitor
0,687  0,004  Antihypertriglyceridemic
0,684  0,005  Histamine release inhibitor
0,679  0,005  Amyloid beta aggregation inhibitor
0,675  0,007  Antiparasitic
0,670  0,007  Nitric oxide antagonist
0,669  0,012  Antihypercholesterolemic
0,659  0,005  Angiogenesis stimulant
0,655  0,004  Hepatoprotectant
0,654  0,005  Antihelmintic
0,650  0,005  Vascular (periferal) disease treatment
0,652  0,008  NOS3 expression inhibitor
0,644  0,009  Cytotoxic
0,639  0,003  Antihypotensive
0,646  0,013  Antibacterial
0,637  0,006  Antiamyloidogenic
0,629  0,006  UDP-glucuronosyltransferase substrate
0,629  0,006  Hypoxia-inducible factor 1 alpha inhibitor
0,611  0,005  Antihypoxic
0,608  0,008  Antiprotozoal (Leishmania)
0,609  0,012  CTGF expression inhibitor
0,615  0,023  TNF expression inhibitor
0,586  0,003  AMP-activated protein kinase stimulant
0,589  0,009  DNA damaging
0,573  0,007  RNA-directed DNA polymerase inhibitor
0,578  0,015  Stroke treatment
0,556  0,004  Platelet adhesion inhibitor
0,553  0,005  Skin whitener
0,550  0,003  Antihemorrhagic
0,541  0,011  UGT1A6 substrate
0,534  0,005  Antidiabetic (type 1)
0,523  0,004  Glutathione S-transferase substrate
0,560  0,042  Antineoplastic (breast cancer)
0,520  0,010  Antineoplastic (osteosarcoma)
0,520  0,010  Vasodilator
0,518  0,010  Antidiabetic symptomatic
0,512  0,005  Interferon gamma antagonist
0,522  0,019  CYP2C19 inhibitor
0,534  0,031  Antineoplastic (colorectal cancer)
0,506  0,005  Insulin secretagoues
0,492  0,006  Sulfotransferase substrate
0,487  0,004  Aldehyde dehydrogenase inhibitor
0,494  0,013  Antineoplastic (lymphoma)
0,499  0,022  Antifungal
0,507  0,032  Teratogen
0,486  0,015  ICAM1 expression inhibitor
0,509  0,046  Alzheimer's disease treatment
0,465  0,003  UDP-glucose 4-epimerase inhibitor
0,475  0,015  DNA synthesis inhibitor
0,475  0,015  UGT2B4 substrate
0,478  0,023  Antiosteoporotic
0,479  0,024  Sensitization
0,488  0,035  Antineoplastic (colon cancer)
0,488  0,037  Antipruritic, allergic
0,476  0,025  Antineoplastic (cervical cancer)
0,466  0,017  Tumour necrosis factor alpha release inhibitor
0,453  0,005  Protein kinase stimulant
0,457  0,010  Antiviral (Herpes)
0,449  0,005  Interleukin 4 antagonist
0,469  0,024  Antineoplastic (brain cancer)
0,447  0,004  Cystathionine beta-synthase inhibitor
0,472  0,032  Bone diseases treatment
0,447  0,009  UGT1A3 substrate
0,437  0,007  Antiviral (Influenza)
0,454  0,027  Antineoplastic (pancreatic cancer)
0,432  0,006  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,452  0,027  Antineoplastic (glioma)
0,424  0,004  SULT1A3 substrate
0,447  0,030  Caspase 3 stimulant
0,452  0,036  Embryotoxic
0,418  0,009  Topoisomerase II inhibitor
0,446  0,038  Immunostimulant
0,435  0,031  Lipoprotein disorders treatment
0,450  0,051  CYP3A4 substrate
0,405  0,007  Alkylator
0,399  0,007  Antiviral (Influenza A)
0,446  0,055  Antineoplastic (lung cancer)
0,394  0,009  UGT2B15 substrate
0,408  0,026  Antineoplastic (glioblastoma multiforme)
0,416  0,042  Respiratory analeptic
0,378  0,012  Antiviral (Hepatitis)
0,369  0,004  Carbonic anhydrase XIII inhibitor
0,417  0,057  CYP2C9 substrate
0,358  0,004  Uric acid excretion stimulant
0,392  0,042  Antiischemic
0,381  0,033  Interleukin 2 agonist
0,354  0,007  UGT2B1 substrate
0,358  0,011  Protein-tyrosine phosphatase inhibitor
0,350  0,004  Carbonic anhydrase III inhibitor
0,372  0,028  Antineoplastic (liver cancer)
0,414  0,072  Calcium channel L-type activator
0,402  0,061  GABA C receptor rho-3 antagonist
0,374  0,033  Antiprotozoal (Trypanosoma)
0,393  0,053  Prostate cancer treatment
0,349  0,010  Antidote
0,373  0,035  Radiosensitizer
0,344  0,006  Aldose reductase substrate
0,348  0,015  Carcinogenic, group 3
0,348  0,016  Antineoplastic (squamous cell carcinoma)
0,383  0,054  Antithrombotic
0,341  0,014  Lipid peroxidase inhibitor
0,335  0,008  Topoisomerase I inhibitor
0,332  0,005  Topoisomerase II alpha inhibitor
0,341  0,015  Antialcoholic
0,392  0,067  Immunosuppressant
0,334  0,014  Antineoplastic (gastric cancer)
0,325  0,008  Antineoplastic antibiotic
0,338  0,029  Antineoplastic enhancer
0,317  0,009  Protein-tyrosine phosphatase 1B inhibitor
0,365  0,059  Cholesterol antagonist
0,335  0,028  Antineoplastic (sarcoma)
0,335  0,030  Cyclic AMP phosphodiesterase inhibitor
0,356  0,055  Antineoplastic (ovarian cancer)
0,301  0,004  Antiviral (Influenza B)
0,347  0,052  Analeptic
0,309  0,015  Diabetic nephropathy treatment
0,315  0,026  P-glycoprotein inhibitor
0,291  0,005  Aldose reductase inhibitor
0,322  0,036  Antineoplastic (lymphocytic leukemia)
0,300  0,016  Insulin sensitizer
0,293  0,010  Antitussive
0,286  0,006  Selectin antagonist
0,316  0,038  GST M1-1 substrate
0,283  0,005  DNA repair enzyme inhibitor
0,282  0,004  Creatine kinase inhibitor
0,288  0,014  NADPH oxidase inhibitor
0,330  0,057  CYP1A2 substrate
0,297  0,026  VCAM1 expression inhibitor
0,330  0,060  Antineoplastic (melanoma)
0,282  0,012  Antiprotozoal (Coccidial)
0,326  0,061  Spasmolytic
0,309  0,047  Myocardial infarction treatment
0,323  0,063  5 Hydroxytryptamine release stimulant
0,282  0,024  Neurotrophic factor enhancer
0,284  0,026  Diabetic retinopathy treatment
0,263  0,015  DNA polymerase I inhibitor
0,268  0,020  Alpha-N-acetylglucosaminidase inhibitor
0,261  0,015  Carcinogenic, group 1
0,251  0,006  NAD(P)H dehydrogenase (quinone) inhibitor
0,270  0,026  Antineoplastic (carcinoma)
0,277  0,036  DNA methylase inhibitor
0,275  0,036  DNA methyltransferase I inhibitor
0,244  0,010  Mediator release inhibitor
0,235  0,001  Sodium/glucose cotransporter inhibitor
0,240  0,009  Beta glucuronidase inhibitor
0,253  0,022  Antiviral (Hepatitis C)
0,348  0,117  5 Hydroxytryptamine release inhibitor
0,255  0,029  Nitric-oxide synthase stimulant
0,240  0,020  Antifungal enhancer
0,300  0,079  Antineoplastic (small cell lung cancer)
0,280  0,060  Platelet antagonist
0,293  0,077  Metabolic disease treatment
0,220  0,003  Anticholelithogenic
0,228  0,015  Expectorant
0,293  0,086  Immunomodulator
0,228  0,022  Antiviral (Hepatitis B)
0,213  0,008  Papain-like protease (SARS coronavirus) inhibitor
0,217  0,014  Cyclooxygenase 3 inhibitor
0,246  0,043  UGT2B7 substrate
0,206  0,006  Potassium channel large-conductance Ca-activated activator
0,236  0,036  Antihelmintic (Nematodes)
0,223  0,022  Psychosexual dysfunction treatment
0,266  0,066  Antineoplastic (bladder cancer)
0,249  0,051  Peptidyltransferase inhibitor
0,208  0,012  Carbonic anhydrase VI inhibitor
0,217  0,021  DNA intercalator
0,212  0,023  Gout treatment
0,217  0,028  Alkaline phosphatase inhibitor
0,198  0,011  NADH dehydrogenase inhibitor
0,300  0,116  Antiobesity
0,207  0,024  Neurotrophic factor
0,191  0,014  Estrogen antagonist
0,177  0,002  Sodium/glucose cotransporter 1 inhibitor
0,201  0,025  Adenylate cyclase inhibitor
0,176  0,001  Sodium/glucose cotransporter 2 inhibitor
0,189  0,015  Gastritis treatment
0,188  0,021  SULT1A1 substrate
0,294  0,128  Antiprotozoal
0,216  0,051  UGT1A4 substrate
0,174  0,011  Thioredoxin inhibitor
0,215  0,052  Antipruritic, non-allergic
0,177  0,015  Antibiotic
0,194  0,034  Mannose-6-phosphate isomerase inhibitor
0,185  0,025  Antineoplastic antimetabolite
0,175  0,016  Multidrug resistance-associated protein 1 inhibitor
0,204  0,046  Liver fibrosis treatment
0,162  0,005  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,200  0,044  Phospholipase C inhibitor
0,322  0,166  Antineoplastic (solid tumors)
0,170  0,015  Phosphofructokinase-1 inhibitor
0,160  0,007  Neuraminidase (influenza) inhibitor
0,227  0,079  Hypolipemic
0,234  0,088  Antineoplastic (renal cancer)
0,201  0,055  VEGF expression inhibitor
0,161  0,018  Carcinogenic, group 2A
0,158  0,017  Aminoacyl-tRNA synthetase inhibitor
0,164  0,024  Antineoplastic (uterine cancer)
0,155  0,018  Triose-phosphate isomerase inhibitor
0,199  0,062  Antiviral (Ebola)
0,143  0,009  Antiviral (Dengue virus)
0,146  0,012  Estrogen agonist
0,153  0,019  Alcohol dehydrogenase inhibitor
0,147  0,017  SULT1E1 substrate
0,243  0,114  Antimycobacterial
0,232  0,104  CYP2C19 substrate
0,138  0,012  Thioredoxin reductase inhibitor
0,158  0,035  Carcinogenic, group 2B
0,131  0,008  Neuraminidase inhibitor
0,129  0,007  Carbonic anhydrase VII inhibitor
0,217  0,096  Aldehyde oxidase inhibitor
0,257  0,137  GST A substrate
0,160  0,040  Antihelmintic (Trematoda)
0,147  0,029  Potassium channel (Ca-activated) activator
0,142  0,025  Toll-Like receptor 4 antagonist
0,182  0,065  Dual specificity phosphatase inhibitor
0,144  0,029  Chronic obstructive bronchitis treatment
0,130  0,016  CDC25A inhibitor
0,225  0,111  5 Hydroxytryptamine uptake stimulant
0,140  0,027  Electron transport complex I inhibitor
0,211  0,099  Antineoplastic (non-small cell lung cancer)
0,133  0,022  Estrogen receptor beta antagonist
0,159  0,049  Adenylate cyclase stimulant
0,142  0,033  Antineoplastic, alkylator
0,166  0,062  Hexokinase inhibitor
0,120  0,016  Na+ K+ transporting ATPase inhibitor
0,131  0,027  Actinic keratosis treatment
0,165  0,062  UGT2B9 substrate
0,138  0,040  Mucolytic
0,108  0,011  Antibiotic Glycopeptide-like
0,136  0,042  Antiviral (Poxvirus)
0,164  0,071  Neurotensin receptor agonist
0,102  0,010  Fatty acid synthase inhibitor
0,163  0,072  Thrombolytic
0,117  0,026  Histidine decarboxylase inhibitor
0,162  0,072  Interleukin 6 antagonist
0,130  0,040  Carbonic anhydrase XV inhibitor
0,246  0,156  Antineoplastic (endocrine cancer)
0,109  0,023  Histone deacetylase SIRT1 stimulant
0,109  0,023  Histone deacetylase stimulant
0,132  0,046  Constipation treatment
0,163  0,077  UGT2B10 substrate
0,098  0,013  Phosphorylase inhibitor
0,150  0,065  Cell wall synthesis inhibitor
0,144  0,061  Heat shock protein 70 antagonist
0,166  0,084  Dual specificity phosphatase 3 inhibitor
0,110  0,029  Telomerase inhibitor
0,151  0,071  Antidiarrheal
0,082  0,004  Cholesterol absorption inhibitor
0,151  0,074  CF transmembrane conductance regulator agonist
0,094  0,018  Postmenopausal disorders treatment
0,131  0,056  Cholesterol synthesis inhibitor
0,184  0,109  Antiviral (HIV)
0,091  0,016  Antimycoplasmal
0,130  0,057  Beta amyloid protein antagonist
0,092  0,019  Xanthine dehydrogenase inhibitor
0,123  0,050  Chelator
0,106  0,034  Transcription factor NF kappa B stimulant
0,117  0,046  Dementia treatment
0,113  0,044  Vascular dementia treatment
0,093  0,026  HIV-1 integrase (Strand Transfer) inhibitor
0,122  0,055  Photosensitizer
0,111  0,044  UGT2B11 substrate
0,090  0,024  Antitreponemal
0,103  0,038  Interleukin 5 antagonist
0,069  0,005  Nucleoside transporters inhibitor
0,163  0,099  Antirickettsial
0,093  0,029  HIV-1 integrase (3'-Processing) inhibitor
0,077  0,013  Alpha-mannosidase inhibitor
0,074  0,011  Glucose-6-phosphate isomerase inhibitor
0,065  0,007  Antibiotic Aminoglycoside-like
0,138  0,081  Cyclooxygenase inhibitor
0,237  0,180  CYP2C9 inhibitor
0,118  0,062  Microtubule formation inhibitor
0,061  0,006  Protein 30S ribosomal subunit inhibitor
0,114  0,059  Choleretic
0,067  0,012  Equilibrative nucleoside transport protein inhibitor
0,078  0,024  Nitric oxide donor
0,137  0,083  Ca2+-transporting ATPase inhibitor
0,104  0,051  Breast cancer-resistant protein inhibitor
0,088  0,035  Lipase inhibitor
0,138  0,085  Peroxidase inhibitor
0,066  0,013  Mannosidase inhibitor
0,110  0,058  HDL-cholesterol increasing
0,067  0,015  Adenosine deaminase inhibitor
0,074  0,023  Mannitol-1-phosphate 5-dehydrogenase inhibitor
0,084  0,034  Carbonic anhydrase VA inhibitor
0,088  0,038  Estrogen receptor alpha antagonist
0,061  0,012  Neuraminidase (Influenza A) inhibitor
0,139  0,091  GABA C receptor rho-2 antagonist
0,225  0,178  Calcium channel activator
0,063  0,017  Estrogen receptor beta agonist
0,055  0,012  Inosine monophosphate dehydrogenase inhibitor
0,078  0,037  Carbonic anhydrase V inhibitor
0,053  0,014  Arginase inhibitor
0,052  0,017  Estrogen receptor alpha agonist
0,105  0,074  Antiviral (Coronavirus)
0,105  0,074  Antiviral (SARS coronavirus)
0,148  0,118  Antineoplastic (bone cancer)
0,107  0,077  Cell adhesion inhibitor
0,174  0,145  Interleukin agonist
0,155  0,127  Antiulcerative
0,185  0,158  CYP2D6 substrate
0,091  0,064  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,114  0,087  Cyclooxygenase 1 inhibitor
0,094  0,067  Sphingomyelinase inhibitor
0,076  0,049  Glutamate dehydrogenase inhibitor
0,054  0,029  Carbonic anhydrase XIV inhibitor
0,059  0,035  Postcoital contraceptive
0,126  0,103  Hemostatic
0,227  0,207  DNA directed DNA polymerase inhibitor
0,119  0,101  Cytidine deaminase inhibitor
0,035  0,017  Estrogen-related receptor beta antagonist
0,029  0,012  Adenosine A1 receptor agonist
0,106  0,089  Growth stimulant
0,153  0,137  Pneumotoxic
0,132  0,116  Myocardial ischemia treatment
0,026  0,010  Inosine monophosphate dehydrogenase 1 inhibitor
0,071  0,057  Adenosine A3 receptor antagonist
0,078  0,064  Antispirochetal
0,052  0,038  Protein 50S ribosomal subunit inhibitor
0,138  0,124  ATPase inhibitor
0,075  0,061  Interferon agonist
0,028  0,015  Toll-Like receptor 4 agonist
0,072  0,059  SULT1A2 substrate
0,110  0,098  Antibacterial (Helicobacter pylori)
0,057  0,047  Antidote, heavy metal
0,018  0,010  Telomerase stimulant
0,039  0,030  DNA-dependent protein kinase inhibitor
0,020  0,012  Antibiotic Anthracycline-like
0,105  0,097  Acetylcholinesterase inhibitor
0,135  0,128  Cardiodepressant
0,028  0,020  1,3-Beta-glucan synthase inhibitor
0,211  0,205  Antineoplastic (non-Hodgkin's lymphoma)
0,038  0,033  Thymidine kinase inhibitor
0,046  0,040  Topoisomerase II beta inhibitor
0,104  0,099  Cyclooxygenase 2 inhibitor
0,136  0,133  LDLR expression enhancer
0,087  0,084  Phosphodiesterase 6D inhibitor
0,029  0,026  ATP citrate lysase inhibitor
0,054  0,052  Lipocortins synthesis agonist
0,041  0,040  Microtubule stabilization
0,010  0,008  Purinergic P2Y2 agonist
0,013  0,012  Adenosine A2b receptor agonist
0,054  0,054  Purinergic P2X1 antagonist
0,020  0,020  Dopamine D1 agonist

